SCM
IMMU

Soleus Capital Management’s Immunomedics Inc IMMU Stock Holding History

Soleus Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-76,268
Closed -$6.49M – 85
2020
Q3 		$6.49M Sell
76,268
-42,732
-36% -$2.16M 3.44% 9
2020
Q2 		$4.22M Buy
+119,000
New +$3.48M 2.4% 14

Soleus Capital Management's IMMU Position: Q4 2020 in Review

Soleus Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 76,268 shares — an estimated $6.49M sold.

Soleus Capital Management first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $6.49M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Soleus Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Soleus Capital Management sold 76,268 Immunomedics Inc shares in Q4 2020, an estimated $6.49M.
  • Soleus Capital Management first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Soleus Capital Management's Immunomedics Inc position peaked at $6.49M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Soleus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.